Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

Thomas Hatschek,Lena Carlsson,Zakaria Einbeigi,Elisabet Lidbrink,Barbro Linderholm,Birgitta Lindh,Niklas Loman,Martin Malmberg,Samuel Rotstein,Martin Söderberg,Marie Sundquist,Thomas M. Walz,Mats Hellström,Helene Svensson,G. Astrom,Yvonne Brandberg,John Carstensen,Mårten Fernö,Jonas Bergh

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

2012

Thomas Hatschek
Lena Carlsson
Zakaria Einbeigi
Elisabet Lidbrink
Barbro Linderholm
Birgitta Lindh
Niklas Loman
Martin Malmberg
Samuel Rotstein
Martin Söderberg
Marie Sundquist
Thomas M. Walz
Mats Hellström
Helene Svensson
G. Astrom
Yvonne Brandberg
John Carstensen
Mårten Fernö
Jonas Bergh

Anthracyclines and taxanes are active cytotoxic drugs in the treatment of early metastatic breast cancer. It is yet unclear whether addition of capecitabine to the combination of these drugs improv ...

Keywords:

Cancer research
Capecitabine
Multicenter trial
Epirubicin
Paclitaxel
Capecitabina
Oncology
Internal medicine
Medicine
Chemotherapy
Metastatic breast cancer
Epirubicina
tailored treatment
first line treatment
first line chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations